scholarly journals Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy

2014 ◽  
Vol 111 (9) ◽  
pp. 3550-3555 ◽  
Author(s):  
Don L. Gibbons ◽  
Sabrina Pricl ◽  
Paola Posocco ◽  
Erik Laurini ◽  
Maurizio Fermeglia ◽  
...  
Keyword(s):  
Molecular Dynamics ◽  
Kinase Inhibitor ◽  
Inhibitor Therapy ◽  
Mechanism Of Resistance ◽  
Unique Mechanism

Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia

2016 ◽  
Vol 91 (11) ◽  
pp. E480-E481 ◽  
Author(s):  
Simone Claudiani ◽  
Jane F. Apperley ◽  
Simona Deplano ◽  
Jamshid Khorashad ◽  
Letizia Foroni ◽  
...  
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Myeloid Leukaemia ◽  
Cognitive Dysfunction ◽  
Kinase Inhibitor ◽  
Inhibitor Therapy ◽  
Tyrosine Kinase Inhibitor Therapy

scholarly journals Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

Leukemia ◽  
2019 ◽  
Vol 33 (8) ◽  
pp. 2116-2120 ◽  
Author(s):  
L. Janssen ◽  
S. J. C. M. Frambach ◽  
N. A. E. Allard ◽  
M. T. E. Hopman ◽  
T. J. J. Schirris ◽  
...  
Keyword(s):  
Skeletal Muscle ◽  
Chronic Myeloid Leukemia ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Myeloid Leukemia ◽  
Kinase Inhibitor ◽  
Inhibitor Therapy ◽  
Tyrosine Kinase Inhibitor Therapy ◽  
Muscle Toxicity
Sign in / Sign up

Export Citation Format

Share Document